2025 second_quarter Filing
Q2Lobbying Activities (4)
Medicare/Medicaid
View allH.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; Inflation Reduction Act (IRA) reform on drug pricing and add on fee (Protecting Patient Access to Cancer and Complex Therapies Act (not reintroduced in 119th)) (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency
Pharmacy
View allH.R. 3164, Ensuring Community Access to Pharmacist Services Act
Manufacturing
View allH.R. 2444, Promoting Resilient Supply Chains Act; S. 257, Promoting Resilient Supply Chains
Health Issues
View allH.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).